{"ticker": {"uuid": "4edac134-e93d-4964-b397-0d57c1c0b22f", "symbol": "ALPN", "name": "Alpine Select AG", "exchange": "EBS", "country": "CH", "sector": "Financial Services", "industry": "Asset Management"}, "articles": [{"title": "Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNbnV1dF9fZ2NLSEFScXZNbGVsaGMza2pnUWFmOGtZZFR0aFFqbHIwZEIzY2hwc0ZEd3BEbTQxVmJ0d0NqZUtmQmdlanFqa2E2Y1hFTmF3ajZYMndKRGdRcDhHT296ZXFVTFBuc1FyN3RUYUNJaGdSM253UnhLYl93bVMxQVhVXzU5WXZ3SmR2R2s?oc=5", "source_name": "Investor's Business Daily", "published_at": "2024-04-11T07:00:00+00:00", "published_display": "11 Apr 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex buying Alpine for $4.9B for phase III-ready IgAN asset", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxONVBGU0xmMW0xWlZIYXl1cDFXOWRuNVozRkNsZHlCU0dSdWIzOTNaTVBQcl9McmUwa0ZWamhMeVViLXlOVjk5UXcyMkQ0TXQxcEZvbno1UWowRDNGUDUzVU82aHNPRThmY0xJV2FCYUhkQTJ4NE9JVXdFRmhkUW4tZVNFMTEwSjZvaWRwY19welYtWEVydWNrMWRoR0NpT0drU3c?oc=5", "source_name": "BioWorld News", "published_at": "2024-04-11T07:00:00+00:00", "published_display": "11 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B\u2014Key Level to Watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOc3pJM0V4Wl9WU0UtMDdpSWFwYkxkc3ZBdVpfcF96akVEMFlGdTRtWlAwbUZoVjJTZE9oVzBrWjJjVlFvenBEMlVkZTdaVkozZmFBYlFia3h6d19ELWxma3VfMzBNcUVGb2JCTm9xd2gwX1NjX0Z3cXZDRVNyWEc4OGNQNWlfSVlmM3dFSnNPQ0V5TVRsdEgxOTVDVG84bmJw?oc=5", "source_name": "Investopedia", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Enters Into Agreement to Acquire Alpine Immune Sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPd3hwSG9iYzN3YW5NTlhBZG0wQ25hUHZhMnZXR0taZVZ2Q25PY2VPcHQ1X1E3UWxrSlpKd2tRSWxJeGZYRmNTVUJRZ2dubG4zOWM3T1Qta2ZfT1kwSDFTY29pR1VBTWdVQ3VxVmRRVUZraUZzR1d6dmhucUttWnNCWTBlUzBWMjFoMnhiOXlqS0o2d3JSeHBPbUtmS3NsVW0wZi1MdVJMWi1HWDdo?oc=5", "source_name": "Stock Titan", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex strikes $4.9B deal for Alpine, expanding work in kidney and autoimmune disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPSGRBaFBCejdpWkh2M2Y0SzV6Rmc4NmdfU3FteloxcmVFZWVKNWZwOGxId0NPT3J5SldUSW9ZSjRXMzBvVmlhbmhpNjhRQnFoQjRrNVVWS2dMZkN4X1paV2RRcVZncjMtakdkSFZic3czLVhUeGVYQ1hIQzJ1eHNPODVsNjRNQXotUVBzMEE2bGhub2h4anM0eTFNOGxfa2JmakIwckZSWm1XMWc?oc=5", "source_name": "Endpoints News", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQaEFqRnM1VWhRWUdkZVd3R3FNSTJRbHM4X09BdHExYmY5eHBfSllNWmE5QnlSd29rRUpNTUluejZGdE1sdnliOFkzT083VjlpZ1dpS1E1aE9zV3dOSUE2R3FnUm5FM1RzZ3ZHQ0pkMjRWOGNMdHNWbDExYTh6YTRXSVczXzV6TmlsV1NSNmsyejd1OG8tUUQ0NnMzUXplaTVpd1VGcmtfN1pZUWJXblhkdjJ5cw?oc=5", "source_name": "BioSpace", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNOHpKMzFxSmZ0ekRrWGY4Q3BBRTZoWHJDZmxWcE9za01IcUwybWU0bVBtX0ZGOUk5TWFWNXZ6RnFiSnRNRjRxdWo1a3JmVE9DQTVxQ2RqamxZN3FvMk5ucl9BemVyOGUzX2RWeHh3cnllRE1jaUw0U3RZTTZDdlVmVHJJZUNLcUljdjAycnFrN3JBN0t1ZUVxYkNJa1BRbDhMOVVZb0ZJWkxDbGdTMVYyRjJ2ZG9FS0QyRzZ3Zkd5TE9mcDUxTGpZaTJlSQ?oc=5", "source_name": "Genetic Engineering and Biotechnology News", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alpine Immune Sciences Announces Pricing of $150 Million Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNTko5SWZ6SWNhcWxnN0xlZ2xvQnF2RGIzSTFLTEFrT01uVGc3djJ5MjRxczVHV043b1pwRmJRc0hxdFllVng2LVVoUjF5aXBYai1SV3BqYnJvQXJyUnFJWXdRTVBCMXBxU3VZMW9IYTlsNEI2SVlqdm5rS2ZfUDNBWU5DOWlKeGd1cERSOVFzMkZRN01WTE9BLV9kU0dlaDlpay1xX0FSR3NUX25Yejg3aFI2elFNRUoydG02czlFNGprZTlBd2o4QWZmOA?oc=5", "source_name": "Business Wire", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNbnV1dF9fZ2NLSEFScXZNbGVsaGMza2pnUWFmOGtZZFR0aFFqbHIwZEIzY2hwc0ZEd3BEbTQxVmJ0d0NqZUtmQmdlanFqa2E2Y1hFTmF3ajZYMndKRGdRcDhHT296ZXFVTFBuc1FyN3RUYUNJaGdSM253UnhLYl93bVMxQVhVXzU5WXZ3SmR2R2s?oc=5", "source_name": "Investor's Business Daily", "published_at": "2024-04-11T07:00:00+00:00", "published_display": "11 Apr 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex buying Alpine for $4.9B for phase III-ready IgAN asset", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxONVBGU0xmMW0xWlZIYXl1cDFXOWRuNVozRkNsZHlCU0dSdWIzOTNaTVBQcl9McmUwa0ZWamhMeVViLXlOVjk5UXcyMkQ0TXQxcEZvbno1UWowRDNGUDUzVU82aHNPRThmY0xJV2FCYUhkQTJ4NE9JVXdFRmhkUW4tZVNFMTEwSjZvaWRwY19welYtWEVydWNrMWRoR0NpT0drU3c?oc=5", "source_name": "BioWorld News", "published_at": "2024-04-11T07:00:00+00:00", "published_display": "11 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B\u2014Key Level to Watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOc3pJM0V4Wl9WU0UtMDdpSWFwYkxkc3ZBdVpfcF96akVEMFlGdTRtWlAwbUZoVjJTZE9oVzBrWjJjVlFvenBEMlVkZTdaVkozZmFBYlFia3h6d19ELWxma3VfMzBNcUVGb2JCTm9xd2gwX1NjX0Z3cXZDRVNyWEc4OGNQNWlfSVlmM3dFSnNPQ0V5TVRsdEgxOTVDVG84bmJw?oc=5", "source_name": "Investopedia", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Enters Into Agreement to Acquire Alpine Immune Sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPd3hwSG9iYzN3YW5NTlhBZG0wQ25hUHZhMnZXR0taZVZ2Q25PY2VPcHQ1X1E3UWxrSlpKd2tRSWxJeGZYRmNTVUJRZ2dubG4zOWM3T1Qta2ZfT1kwSDFTY29pR1VBTWdVQ3VxVmRRVUZraUZzR1d6dmhucUttWnNCWTBlUzBWMjFoMnhiOXlqS0o2d3JSeHBPbUtmS3NsVW0wZi1MdVJMWi1HWDdo?oc=5", "source_name": "Stock Titan", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex strikes $4.9B deal for Alpine, expanding work in kidney and autoimmune disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPSGRBaFBCejdpWkh2M2Y0SzV6Rmc4NmdfU3FteloxcmVFZWVKNWZwOGxId0NPT3J5SldUSW9ZSjRXMzBvVmlhbmhpNjhRQnFoQjRrNVVWS2dMZkN4X1paV2RRcVZncjMtakdkSFZic3czLVhUeGVYQ1hIQzJ1eHNPODVsNjRNQXotUVBzMEE2bGhub2h4anM0eTFNOGxfa2JmakIwckZSWm1XMWc?oc=5", "source_name": "Endpoints News", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQaEFqRnM1VWhRWUdkZVd3R3FNSTJRbHM4X09BdHExYmY5eHBfSllNWmE5QnlSd29rRUpNTUluejZGdE1sdnliOFkzT083VjlpZ1dpS1E1aE9zV3dOSUE2R3FnUm5FM1RzZ3ZHQ0pkMjRWOGNMdHNWbDExYTh6YTRXSVczXzV6TmlsV1NSNmsyejd1OG8tUUQ0NnMzUXplaTVpd1VGcmtfN1pZUWJXblhkdjJ5cw?oc=5", "source_name": "BioSpace", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNOHpKMzFxSmZ0ekRrWGY4Q3BBRTZoWHJDZmxWcE9za01IcUwybWU0bVBtX0ZGOUk5TWFWNXZ6RnFiSnRNRjRxdWo1a3JmVE9DQTVxQ2RqamxZN3FvMk5ucl9BemVyOGUzX2RWeHh3cnllRE1jaUw0U3RZTTZDdlVmVHJJZUNLcUljdjAycnFrN3JBN0t1ZUVxYkNJa1BRbDhMOVVZb0ZJWkxDbGdTMVYyRjJ2ZG9FS0QyRzZ3Zkd5TE9mcDUxTGpZaTJlSQ?oc=5", "source_name": "Genetic Engineering and Biotechnology News", "published_at": "2024-04-10T07:00:00+00:00", "published_display": "10 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alpine Immune Sciences Announces Pricing of $150 Million Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNTko5SWZ6SWNhcWxnN0xlZ2xvQnF2RGIzSTFLTEFrT01uVGc3djJ5MjRxczVHV043b1pwRmJRc0hxdFllVng2LVVoUjF5aXBYai1SV3BqYnJvQXJyUnFJWXdRTVBCMXBxU3VZMW9IYTlsNEI2SVlqdm5rS2ZfUDNBWU5DOWlKeGd1cERSOVFzMkZRN01WTE9BLV9kU0dlaDlpay1xX0FSR3NUX25Yejg3aFI2elFNRUoydG02czlFNGprZTlBd2o4QWZmOA?oc=5", "source_name": "Business Wire", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 8, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 6, "score": 54, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 9.35, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 3.3, "twelve_week_move": 9.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.244533, "market_dynamics_buy_signal": false, "relative_strength": 1.527513, "fair_value_gap": 24.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.7108, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +3.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Investor's Business Daily", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "Investopedia", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Endpoints News", "count": 1}, {"label": "BioSpace", "count": 1}, {"label": "Genetic Engineering and Biotechnology News", "count": 1}, {"label": "Business Wire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +3.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It"}], "updated_at": "2026-07-17T12:01:14.815406+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}